StockData
Alpha Teknova, Inc. logo

Alpha Teknova, Inc. (TKNO) stock

TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30125% above fair value
$7.77−0.44 (-5.36%)

Close on Nov 16, 2026Market cap $417.16MP/E –Yield –

Alpha Teknova total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Alpha Teknova's total debt was $0 at Dec 31, 2025. For fiscal 2025 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2024Dec 31, 2024$4.05M-69.5%
FY2023Dec 31, 2023$13.25M-39.7%
FY2022Dec 31, 2022$21.98M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2024Dec 31, 2024$4.05M-69.5%
Q3 FY2024Sep 30, 2024$13.39M+1.6%
Q2 FY2024Jun 30, 2024$13.28M-40.1%
Q1 FY2024Mar 31, 2024$13.18M-40.0%
Q4 FY2023Dec 31, 2023$13.25M–
Q3 FY2023Sep 30, 2023$13.17M–
Q2 FY2023Jun 30, 2023$22.16M–
Q4 FY2022Dec 31, 2022$21.98M–

More Alpha Teknova figures

See a number that looks wrong?